CervoMed Inc. - Common Stock —— 现金流量表 (NASDAQ:CRVO) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -13.55 M-14.5 M-14.97 M-7.45 M-16.53 M-23.45 M -27.57 M 投资活动产生的现金 —4 000-12.24 M—-28.66 M18.1 M 20.41 M 融资活动产生的现金 17.89 M33.3 M5 00011.15 M46.4 M4.59 M 4.6 M 自由现金流 -13.55 M-14.5 M-14.97 M-7.45 M-16.53 M-23.45 M -27.57 M

新闻

Pelthos Therapeutics Inc. (PTHS) Reports Q1 Loss, Beats Revenue Estimates

Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates

IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Misses Revenue Estimates

H.C. Wainwright重申CervoMed股票评级,基于会议数据

H.C. Wainwright reiterates CervoMed stock rating on conference data

CervoMed Inc. (CRVO) Reports Q4 Loss, Lags Revenue Estimates

Buy 2 ‘Strong Buy’ Biotech Stocks With 400%+ Upside, According to Wall Street - TipRanks.com

CervoMed确定第三阶段痴呆症试验50毫克剂量

CervoMed sets 50mg dose for phase 3 dementia trial

Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards?

CervoMed的neflamapimod入选英国ALS试验平台

CervoMed’s neflamapimod selected for UK ALS trial platform